CRY2, casein kinase 1 delta (CSNK1D), f-box and leucine-rich repeat protein 21 (FBXL21), and PER1, for the prognosis of HCC and the prediction of immune infiltration sensitivity [164]. This evidence concerns the gene CRY2 and hepatocellular carcinoma.